Avanos Medical appoints new chief financial officer

December 30, 2019

Avanos Medical (NYSE:AVNS) today said it appointed Michael Greiner as senior VP and chief financial officer, effective Jan. 1. Greiner will be responsible for the Alpharetta, Ga.-based company’s global finance and information technology organizations. He will report to CEO Joe Woody. Prior to joining Avanos Medical, Greiner served as executive VP and CFO of AngioDynamics. He…

Read More

Clearside Biomedical Announces Option Exercise by REGENXBIO for Global License for Use of SCS Microinjector™ in AAV Gene Therapy Delivery

October 30, 2019

ALPHARETTA, Ga., Oct. 30, 2019 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that REGENXBIO Inc. (Nasdaq: RGNX) has exercised its option under the previously announced option and license agreement to…

Read More

NIH awards up to $130M for flu vaccine development to University of Georgia

September 30, 2019

UGA to lead effort aimed at protecting vulnerable populations The University of Georgia has signed a contract with the National Institutes of Health for an initial award of $8 million to develop a new, more advanced influenza vaccine designed to protect against multiple strains of influenza virus in a single dose. The total funding could be up to…

Read More